Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH ENDOMETRIAL CANCER - AGYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(4), 1998, pp. 406-407
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH MIXED MESODERMAL TUMORS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(3), 1998, pp. 306-307
Authors:
ASBURY R
BLESSING JA
BULLER R
MALFETANO JH
WALKER J
SEVIN BU
Citation: R. Asbury et al., AMONAFIDE IN PATIENTS WITH LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(2), 1998, pp. 145-146
Authors:
ASBURY R
BLESSING JA
LOOK KY
BULLER R
LUCCI JA
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 20(6), 1997, pp. 626-627
Authors:
CHANG AY
BOROS L
ASBURY R
HUI LF
RUBINS J
Citation: Ay. Chang et al., DOSE-ESCALATION STUDY OF WEEKLY 1-HOUR PACLITAXEL ADMINISTRATION IN PATIENTS WITH REFRACTORY CANCER, Seminars in oncology, 24(5), 1997, pp. 69-71
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMINOTHIADIAZOLE IN PATIENTS WITH MIXED MESODERMAL TUMORS OF THE UTERINE CORPUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(4), 1996, pp. 400-402
Authors:
REISINGER SA
ASBURY R
LIAO SY
HOMESLEY HD
Citation: Sa. Reisinger et al., A PHASE-I STUDY OF WEEKLY CISPLATIN AND WHOLE ABDOMINAL RADIATION FORTHE TREATMENT OF STAGE-III AND STAGE-IV ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY, Gynecologic oncology, 63(3), 1996, pp. 299-303
Citation: R. Asbury et al., AMINOTHIADIAZOLE IN THE TREATMENT OF ADVANCED LEIOMYOSARCOMA OF THE UTERINE CORPUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(5), 1995, pp. 397-399
Citation: Ay. Chang et al., PACLITAXEL BY 3-HOUR INFUSION FOLLOWED BY 96-HOUR INFUSION ON FAILUREIN PATIENTS WITH REFRACTORY MALIGNANT DISEASE, Seminars in oncology, 22(3), 1995, pp. 124-127
Citation: Rk. Hsieh et al., PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, American journal of clinical oncology, 17(6), 1994, pp. 509-513